# Page 1
Administrative approval for procurement of essential kits, equipment and medical supplies under Blood Cell, Sickle Cell and Hematology programme under National Health Mission (NHM) for the year 2019-20 and committed grants for the year 2018-19.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-0919/ PR No.474/ HEALTH-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
Date is September 13, 2019.
(1) Joint Director (Technical), National Health Mission, Mumbai, dated 11.09.2019 vide No. RASO/ State Blood Cell/ PRASHAMA 50%/ 58761/2019 dated 03.09.2019.
Consent note from the Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai dated 02.08.2019 and dated 09.09.2019.
The Proposal:
Under National Health Mission (NHM) for the year 2019-20 and 2018-19
Kits required under Blood Cell, Sickle Cell and Hematology programmes from committed grants.
Administrative approval for purchase of equipment and medical supplies
was under consideration.
Government's decision:
Project Implementation Plan approved by the Central Government for the year 2019-20 under Blood Cell
Essential for effective implementation and achievement of objectives of the Haematology and Sickle Cell Programme
Subsidies available for purchase of equipment, materials, kits and medicines etc.
approved in 2018-19 and approved in 2019-20.
Procurement of medicines required for treatment of Haemophilia and Thalassemia patients through subsidy.
# Page 2
Government Resolution No: PRASHAMA-0919/ PR No.474/ HEALTH-7
Haffkine to make purchases subject to the following conditions:
Administrative approval for procurement is being given at the level of Bio Pharmaceuticals, Mumbai.
the prospectus
-----------------------------------------------------------------------------------------------------------------------------
| SR. No        | F.M.R. Code | Name of Item / Medicine / Kits  | Qty    | Rate Inclusive All (In Rs.) | Total Amt (In Rs.) |
| 1.            | 6.1.1.9.a   | Blast Freezers                  | 08     | 3600000.00                  | 28000000.00        |
| 2.            | 6.2.7.1     | Solubility Kits                 | 24976  | 500.00                      | 12488000.00        |
| 3.            | 6.2.7.1     | Electrophoresis Kits            | 876    | 12000.00                    | 10512000.00        |
| IVIG-Strength | No.of Vials |
| 4.            | 6.2.7.1     | 2.5% (2.5gm/100ml)              | 1850   | 3500.00                     | 6475000.00         |
| 5.            | 6.2.7.1     | 5% (5gm/100ml )                 | 1841   | 7500.00                     | 13808000.00        |
| 7.            | 6.2.7.1     | 10% (10gm/100ml)                | 981    | 15000.00                    | 14715000.00        |
| 8             | 6.2.7.2     | Tab.Deferasirox,250mg           | 850000 | 7.28                        | 6188000.00         |
| 9             | 6.2.7.2     | Tab.Deferasirox,500mg           | 694500 | 12.32                       | 8556240.00         |
| 10            | 6.2.7.2     | Tab.Deferiprone,250mg           | 68200  | 4.36                        | 297352.00          |
| 11            | 6.2.7.2     | Tab.Deferiprone,500mg           | 52056  | 7.62                        | 396666.72          |
| 12            | 6.2.7.2     | Injection Desferal, 500mg       | 15000  | 150.00                      | 2250000.00         |
| 13            | 6.2.7.2     | Tablet Hydroxyurea, 500mg       | 117750 | 3.66                        | 430965.00          |
| 14            | 6.2.7.2     | Factor VII,1mg                  | 1200   | 41275.50                    | 49530600.00        |
| 15            | 6.2.7.2     | Factor VIII PD, 250 IU          | 24500  | 1782.00                     | 43667550.00        |
| 16            | 6.2.7.2     | Factor VIII with VWF, 250 IU    | 7000   | 2025.00                     | 14175000.00        |
| 17            | 6.2.7.2     | Factor VIII Recombinant, 250 IU | 63892  | 2509.00                     | 160320475.00       |
| 18            | 6.2.7.2     | Factor IX, 600 IU               | 6002   | 8694.00                     | 52181388.00        |
| 19            | 6.2.7.2     | APCC / FEIBA, 500 IU            | 3856   | 27615.00                    | 106483440.00       |
-----------------------------------------------------------------------------------------------------------------------------
Page 2 of 5
# Page 3
Government Resolution No: PRASHAMA-0919/ PR No.474/ HEALTH-7
Conditions: 1) The requirement/ demand for the said medicinal and material materials should be ascertained. In case of urgency, some items may be purchased as per requirement by way of re-issue order at the minimum price received in the tender floated with Haffkine Bio Pharmaceuticals Pvt. Ltd., Purchase Cell, Mumbai.
2) It should be ensured that the specifications of the said medicines and materials are as per the requirement and up to date. The technical specifications of the items to be procured should be as per the specifications agreed by the concerned experts (Technical Committee/ Officials).
Also, it should be ensured that the technical specification is not designed in such a way that it will benefit any particular company. The responsibility of sending the requisition as per the technical specifications of the items approved in the PIP will be of the concerned programme head. Only the items included in the proposal should be purchased.
(3) The prescribed procurement procedure should be carried out in accordance with the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labor Department, No. 2014/ PR No. 82/ Part-II/ Industry 4, dated December 1, 2016.
4) The rates of the proposed procurement are estimated at the time of granting administrative approval. Therefore, the minimum prices available on the GeM Portal, other state tariffs, National Pharmaceutical Pricing Authority (NPPA), National Medical Devices Authority (NDMA) should be considered. Also, the minimum rates received in the tender, if any, in respect of drugs, pharmaceuticals and equipment, if these items are being purchased or have been purchased in Haffkine Institute, shall be recorded as estimated rates in respect of drugs, pharmaceuticals and equipment to the tenderers and the rates shall be determined at the end of the procurement process. It should be ensured that the price is less than the market price and not more than the rate at which the supplier has supplied the item to other places.
5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
6) Storage and distribution of the items to be purchased after supply, supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
Page 3 of 5
# Page 4
Government Resolution No: PRASHAMA-0919/ PR No.474/ HEALTH-7
The expenditure for procurement of these seeds is as per the FMR Code 6.2.7.2 approved in the Project Implementation Action Plan under National Health Mission (NHM), Government of India for 2018-19. 2888.00 lakh out of the total grant of Rs. 1866.79 lakh is to be met from the grants and the grants available under headings 6.1.1.93, 6.2.7.1 for the year 2019-20. Also, the purchase should be made within the prescribed limit of the approved subsidy. The procurement should be completed within the stipulated period of administrative approval.
8) Also, it should be ensured that there is no duplication in the purchase of these items.
The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A to Rule No.4 of the Financial Powers Rules, 1978, Part-I Sub-Section-II. 7 in front of No. 6 conditions must be met.
Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process. In this regard, the Public Health Department, vide Government Resolution No. Procurement should be carried out in accordance with the provisions of the Government Decision of 2016/ EC 240/ Health-8 dated July 26, 2017.
to fulfil the conditions mentioned in the above sequence numbers 1 to 11 and as per the rules of procurement and
The Commissioner (Health Services) and the Mission are fully responsible for ensuring that the requirement is met.
Director, National Health Mission, Mumbai, Director (Health Services), Directorate General of Health Services, Mumbai,
Joint Director, Health Services (Purchase Cell), Directorate of Health Services, Mumbai and Programme Head
will remain.
GOVERNMENT DECISION, DEPARTMENT OF FINANCE, NO. VIAPRA-2013/ P.S. 30/13/ REGULATIONS, PART II, DATED 17
The Financial Powers Rules, 1978, Part-I, Sub-Section-II, dated April, 2015
Rule No. 4. 7 to purchase tools, spare parts and equipment
The administrative department has been given full powers to grant approval.
The government is taking decisions.
Page 4 of 4
# Page 5
Government Resolution No: PRASHAMA-0919/ PR No.474/ HEALTH-7